Sex-Based Vaccine Response in the Context of COVID-19.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

32 citing papers in PubMed.

1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.Lancet (London, England) · 2021
   Trial
2. Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine.Narra J · 2024
   Article
3. Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece.Vacunas · 2023
   Article
4. Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review.Communications medicine · 2023
   Article
5. Manifestations of adverse events post Sinovac vaccine immunization at Wirasakti Hospital, Kupang.Journal of public health in Africa · 2023
   Article
6. The Course of COVID-19 among Unvaccinated Patients-Data from the National Hospital in Warsaw, Poland.Vaccines · 2023
   Article
7. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.Journal of pharmaceutical policy and practice · 2023
   Article
8. Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study.Vaccines · 2023
   Article
9. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.Vaccine · 2022
   Article
10. Self-Reported Reactogenicity After Different COVID-19 Vaccination Regimens—an Analysis of Registry-Based Data.Deutsches Arzteblatt international · 2022
    Article
11. Coronavirus Vaccination: Spike Antibody Levels in Health Workers after Six Months-A Cross-Sectional Study.International journal of environmental research and public health · 2022
    Article
12. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.Viruses · 2022
    Article
13. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort.International journal of rheumatic diseases · 2022
    Article
14. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity.Molecular biomedicine · 2022
    Review
15. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance.EClinicalMedicine · 2022
    Article
16. Attention for sex in COVID-19 trials: a review of regulatory dossiers.BMJ global health · 2022
    Review
17. Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
18. Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.Vaccines · 2022
    Article
19. Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study.Infection and drug resistance · 2022
    Article
20. Side Effects and Perceptions of COVID-19 Vaccination in Saudi Arabia: A Cross-Sectional Study.Frontiers in medicine · 2022
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as